Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Hormone Treatment”

470 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 470 results

Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)UnknownNCT04318223
What this trial is testing

Palbociclib Plus Fulvestrant in Women With Hormone Receptor Positive and Human Epidermal Growth Factor Receptor Type 2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With a CDK4/6 Inhibitor in Combination With Hormonal Therapy

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast Cancer
Consorzio Oncotech 168
Large-scale testing (Phase 3)WithdrawnNCT00256555
What this trial is testing

Growth Hormone Treatment Study in Children With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT01746862
What this trial is testing

Evaluate the Safety and Efficacy of Saizen® in Children With Idiopathic Short Stature (ISS)

Who this might be right for
Idiopathic Short Stature
Merck KGaA, Darmstadt, Germany 90
Not applicableStudy completedNCT01263457
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in the UK

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 191
Not applicableStudy completedNCT01616095
What this trial is testing

Effects of Growth Hormone Supplementation to Adults With Growth Hormone Deficient on Metabolism and Adipose Tissue Molecular Phenotype

Who this might be right for
Growth Hormone Deficiency
Slovak Academy of Sciences 44
Large-scale testing (Phase 3)Ended earlyNCT06038539
What this trial is testing

Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer

Who this might be right for
HR Negative HER2 Positive Early Breast Cancer or Locally Advanced Breast Cancer Patients
Biocon Biologics UK Ltd 55
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07264595
What this trial is testing

A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)

Who this might be right for
Pediatric Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd. 88
Testing effectiveness (Phase 2)Study completedNCT00130286
What this trial is testing

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Who this might be right for
HIV-Associated Lipodystrophy SyndromeInsulin ResistanceHIV Infections+2 more
Weill Medical College of Cornell University 77
Post-approval studies (Phase 4)Ended earlyNCT00555009
What this trial is testing

Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury

Who this might be right for
Brain InjuriesGrowth Hormone Deficiency
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT00294619
What this trial is testing

Treatment of Adults With Growth Hormone Deficiency

Who this might be right for
Pituitary DisordersAdult Growth Hormone Deficiency
LG Life Sciences 147
Testing effectiveness (Phase 2)WithdrawnNCT01647412
What this trial is testing

Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease

Who this might be right for
Crohn's Disease
Columbia University
Testing effectiveness (Phase 2)UnknownNCT03104010
What this trial is testing

A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD

Who this might be right for
Adult Growth Hormone Deficiency
Changchun GeneScience Pharmaceutical Co., Ltd. 180
Not applicableLooking for participantsNCT06127979
What this trial is testing

Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01718041
What this trial is testing

Versartis Trial in Children to Assess Long-Acting Growth Hormone

Who this might be right for
Pediatric Growth Hormone Deficiency
Versartis Inc. 64
Not applicableStudy completedNCT00960128
What this trial is testing

Observational Prospective Study on Patients Treated With Norditropin®

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenAdult Growth Hormone Deficiency+7 more
Novo Nordisk A/S 21,249
Post-approval studies (Phase 4)Study completedNCT01697644
What this trial is testing

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Who this might be right for
Foetal Growth ProblemSmall for Gestational Age
Novo Nordisk A/S 75
Testing effectiveness (Phase 2)Looking for participantsNCT05355272
What this trial is testing

Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)

Who this might be right for
Gulf War SyndromeAdult Growth Hormone Deficiency
Baylor College of Medicine 20
Not applicableStudy completedNCT02152124
What this trial is testing

Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?

Who this might be right for
Acromegaly
University Hospital, Ghent 21
Not applicableStudy completedNCT01327924
What this trial is testing

Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone

Who this might be right for
Growth Hormone DisorderGrowth Hormone Deficiency in ChildrenGenetic Disorder+6 more
Novo Nordisk A/S 77
Load More Results